Chao Liu

Chao Liu

Auto-generated profile, based on publicly available information

Chao Liu

Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
CLChao Liu
Chao Liu
YFYue Fan
Yue Fan
LZLu Zhou
Lu Zhou
HZHong-Yi Zhu
Hong-Yi Zhu
YSYi-Chen Song
Yi-Chen Song
QLQingping Li
Qingping Li

8 September 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
HSHui Shi
Hui Shi
AGAlex A. Gandhi
Alex A. Gandhi
SSStephanie A. Smith
Stephanie A. Smith
QWQiuyu Wang
Qiuyu Wang
DCDiane Chiang
Diane Chiang
JKJason Knight
Jason Knight
Neutrophil-mediated activation and injury of the endothelium play roles in the pathogenesis of diverse disease states ranging from autoimmunity to cancer to COVID-19. Neutralization of cationic proteins (such as neutrophil extracellular trap–derived [NET-derived] histones) with polyanionic compounds has been suggested as a potential strategy for protecting the endothelium from such insults. Here, we report that the US Food and Drug Administration–approved polyanionic agent defibrotide (a pleiotropic mixture of oligonucleotides) directly engages histones and thereby blocks their pathological effects on endothelium. In vitro, defibrotide counteracted endothelial cell activation and pyroptosis-mediated cell death, whether triggered by purified NETs or recombinant histone H4. In vivo, defibrotide stabilized the endothelium and protected against histone-accelerated inferior vena cava thrombosis in mice. Mechanistically, defibrotide demonstrated direct and tight binding to histone H4 as detected by both electrophoretic mobility shift assay and surface plasmon resonance. Taken together, these data provide insights into the potential role of polyanionic compounds in protecting the endothelium from thromboinflammation with potential implications for myriad NET- and histone-accelerated disease states.

27 October 2023 in Science Advances
Verified
Journal Article
Open access
CLChao Liu
Chao Liu
SYSrilakshmi Yalavarthi
Srilakshmi Yalavarthi
ATAjay Tambralli
Ajay Tambralli
LZLixia Zeng
Lixia Zeng
CRChristine E. Rysenga
Christine E. Rysenga
JKJason Knight
Jason Knight
While neutrophil extracellular traps (NETs) have previously been linked to some diabetes-associated complications, such as dysfunctional wound healing, their potential role in diabetic vascular dysfunction has not been studied. Diabetic Akita mice were crossed with either Elane −/− or Pad4 −/− mice to generate NET-deficient diabetic mice. By 24 weeks of age, Akita aortae showed markedly impaired relaxation in response to acetylcholine, indicative of vascular dysfunction. Both Akita- Elane −/− mice and Akita- Pad4 −/− mice had reduced levels of circulating NETs and improved acetylcholine-mediated aortic relaxation. Compared with wild-type aortae, the thromboxane metabolite TXB 2 was roughly 10-fold higher in both intact and endothelium-denuded aortae of Akita mice. In contrast, Akita- Elane −/− and Akita- Pad4 −/− aortae had TXB 2 levels similar to wild type. In summary, inhibition of NETosis by two independent strategies prevented the development of vascular dysfunction in diabetic Akita mice. Thromboxane was up-regulated in the vessel walls of NETosis-competent diabetic mice, suggesting a role for neutrophils in driving the production of this vasoconstrictive and atherogenic prostanoid.

20 October 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CLChao Liu
Chao Liu
JZJing-Wen Zhang
Jing-Wen Zhang
LHLiang Hu
Liang Hu
YSYi-Chen Song
Yi-Chen Song
LZLu Zhou
Lu Zhou
QLQingping Li
Qingping Li
A local renin-angiotensin system (RAS) is expressed in mesenchymal stem cells (MSCs) and regulates stem cell function. The local RAS influences the survival and tissue repairing ability of transplanted stem cells. We have previously reported that angiotensin II (Ang II) pretreatment can significantly increase vascular endothelial growth factor (VEGF) synthesis in MSCs through the ERK1/2 and Akt pathways via the Ang II receptor type 1 (AT1R). However, the role of angiotensin-converting enzyme (ACE) has not been clarified. Furthermore, whether Ang II pretreatment activates hypoxia-inducible factor-1α(HIF-1α) in MSCs has not been elucidated. Our data show that both ACE and HIF-1αare involved in promoting VEGF expression in MSCs, and that both are upregulated by Ang II stimulation. The upregulation of ACE appeared after the rapid degradation of exogenous Ang II, and led to the formation of endogenous Ang II. On the other hand, the ACE inhibitor, captopril, attenuated Ang II-enhanced HIF-1αupregulation, while HIF-1αsuppression markedly attenuated ACE expression. This interesting finding suggests an interaction between ACE and HIF-1α. We conclude that Ang II pretreatment, as a trigger, activated the AT1R/HIF-1α/ACE axis that then mediated Ang II-induced VEGF synthesis in MSCs.

5 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
CLChao Liu
Chao Liu
YFYue Fan
Yue Fan
HZHong-Yi Zhu
Hong-Yi Zhu
LZLu Zhou
Lu Zhou
YWYu Wang
Yu Wang
QLQingping Li
Qingping Li
Background: Angiotensin-converting enzyme-2 (ACE2) overexpression improves left ventricular remodeling and function in diabetic cardiomyopathy; however, the effect of ACE2-overexpressed mesenchymal stem cells (MSCs) on myocardial infarction (MI) remains unexplored. This study aimed to investigate the effect of ACE2-overexpression on the function of MSCs and the therapeutic efficacy of MSCs for MI. Methods: MSCs were transfected with Ace2 gene using lentivirus, and then transplanted into the border zone of ischemic heart. The renin-angiotensin system (RAS) expression, nitric oxide synthase (NOS) expression, paracrine factors, anti-hypoxia ability, tube formation of MSCs, and heart function were determined. Results: MSCs expressed little ACE2. ACE2-overexpression decreased the expression of AT1 and VEGF apparently, up-regulated the paracrine of HGF, and increased the synthesis of Angiotensin 1-7 in vitro. ACE2-overexpressed MSCs showed a cytoprotective effect on cardiomyocyte, and an interesting tube formation ability, decreased the heart fibrosis and infarct size, and improved the heart function. Conclusion: Therapies employing MSCs with ACE2 overexpression may represent an effective treatment for improving the myocardium microenvironment and the cardiac function after MI.

8 April 2022 in Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
Verified
Journal Article
Closed access
HHH J Hua
H J Hua
HSHaoyao Sun
Haoyao Sun
CLC Liu
C Liu
QYQ Y Yang
Q Y Yang
YDYiyi Ding
Yiyi Ding
HLH Li
H Li